Autonomic dysfunction in peripheral nerve disease

Muscle and Nerve

Volumn 27, Issue 6, 2003, Pages 646-661

  Low, Phillip A ^a   Vernino, Steven ^a   Suarez, Guillermo ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmune autonomic neuropathy; Autonomic; Ganglionic antibody; Paraneoplastic; Thermoregulatory sweat test

Indexed keywords

2 HEXANONE; ACRYLAMIDE; AMIODARONE; ANTITOXIN; APOLIPOPROTEIN A1; ARSENIC; AUTOANTIBODY; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CISPLATIN; FLUDROCORTISONE; GELSOLIN; GUANIDINE; HEAVY METAL; HEXANE; IMMUNOGLOBULIN; MERCURY; MIDODRINE; NEUROTOXIN; PAPAVERINE; PERHEXILINE MALEATE; PROSTAGLANDIN E1; SILDENAFIL; THALLIUM; TRI MIX; UNINDEXED DRUG; VASOCONSTRICTOR AGENT; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; VINDESINE; YOHIMBINE;

AMYLOID NEUROPATHY; ANTIBODY TITER; AUTOIMMUNE DISEASE; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; BOTULISM; CHRONIC DISEASE; DIABETIC NEUROPATHY; DISTAL SMALL FIBER NEUROPATHY; DRUG EFFICACY; DRUG INDUCED DISEASE; DYSAUTONOMIA; ERECTILE DYSFUNCTION; FAMILIAL AMYLOID POLYNEUROPATHY; GENE MUTATION; GENETIC DISORDER; GUILLAIN BARRE SYNDROME; HUMAN; IDIOPATHIC DISEASE; INTOXICATION; LABORATORY TEST; MOLECULAR GENETICS; MYASTHENIA GRAVIS; NEUROTOXICITY; ORTHOSTATIC HYPERTENSION; PARANEOPLASTIC SYNDROME; PARASYMPATHETIC NERVE; PERIPHERAL NEUROPATHY; PORPHYRIA; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRIORITY JOURNAL; REVIEW; SYMPATHETIC NERVE; TACHYCARDIA; THYMOMA;

NON-PROGRAMMATIC;

AMYLOID NEUROPATHIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETIC NEUROPATHIES; HUMANS; NEUROTOXINS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0037533684     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10333     Document Type: Review

References (124)

1. Abelson D. Diagnostic value of the penile pulse and blood pressure: a Doppler study of impotence in diabetics. J Urol 1975;113:636-639.
2. Achem-Karam SR, Funakoshi A, Vinik AI, Owyang C. Plasma motilin concentration and interdigestive migrating motor complex in diabetic gastroparesis: effect of metoclopramide. Gastroenterology 1985;88:492-499.
3. Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Plante V, Ducot B, Ichai P, Lacroix C, Metral S, Bismuth H, Said G. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000;123:1495-1504.
4. Appenzeller O, Kornfeld M. Acute pandysautonomia. Clinical and morphologic study. Arch Neurol 1973;29:334-339.
5. Axelrod FB. Familial dysautonomia: a 47-year perspective. How technology confirms clinical acumen. J Pediatr 1998;132:S2-S5.
6. Baldwa VS, Ewing DJ. Heart rate response to Valsalva manoeuvre. Reproducibility in normals, and relation to variation in resting heart rate in diabetics. Br Heart J 1977;39:641-644.
7. Bank WJ, Pleasure DE, Suzuki K, Nigro M, Katz R. Thallium poisoning. Arch Neurol 1972;26:456-464.
8. Battle WM, Snape NJ, Jr., Alavi A, Cohen S, Braunstein S. Colonic dysfunction in diabetes mellitus. Gastroenterology 1980;79:1217-1221.
9. Bejaoui K, Wu C, Scheffler MD, Haan G, Ashby P, Wu L, de Jong P, Brown RHJ. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat Genet 2001;27:261-262.
10. Bellavere F, Bosello G, Cardone C, Girardello L, Ferri M, Fedele D. Evidence of early impairment of parasympathetic reflexes in insulin dependent diabetics without autonomic symptoms. Diabetes Metab 1985;11:152-156.
11. Bennett JL, Mahalingam R, Wellish MC, Gilden DH. Epstein-Barr virus-associated acute autonomic neuropathy. Ann Neurol 1996;40:453-455.
12. Bennett T, Hosking DJ, Hampton JR. Baroreflex sensitivity and responses to the Valsalva manoeuvre in subjects with diabetes mellitus. J Neurol Neurosurg Psychiatry 1976;39:178-183.
13. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996;78:257-261.
14. Burns TM, Lawn NC, Low PA, Camilleri M, Wijdicks EFM. Adynamic ileus in severe Guillain-Barré syndrome. Muscle Nerve 2001;24:963-965.
15. Camilleri M. Autonomic regulation of gastrointestinal motility. In: Low PA, editor. Clinical autonomic disorders: evaluation and management. Boston: Little, Brown; 1993. p 125-132.
16. Camilleri M, Balm RK, Low PA. Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction. Clin Auton Res 1993;3:95-100.
17. Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984;14:420-427.
18. Chan KH, Vernino S, Lennon VA. ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol 2001;50:301-311.
19. Chang CM, Yu CW, Fong KY, Leung SY, Tsin TW, Yu YL, Cheung TF, Chan SY. N-hexane neuropathy in offset printers. J Neurol Neurosurg Psychiatry 1993;56:538-542.
20. Cherington M, Ryan DW. Treatment of botulism and guanidine. N Engl J Med 1970;282:195-197.
21. Colan RV, Snead OC, III, Oh SJ, Kashlan MB. Acute autonomic and sensory neuropathy. Ann Neurol 1980;8:441-444.
22. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 1992;71:59-72.
23. Dawkins JL, Huhne DJ, Brahmbhatt SB, Auer-Grumbach M, Nicholson GA. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet 2001;27:309-312.
24. De Palma RG. New developments in the diagnosis and treatment of impotence. West J Med 1996;164:54-61.
25. DeWire DM. Evaluation and treatment of erectile dysfunction. Am Fam Physician 1996;53:2101-2108.
26. Dyck PJ, Karnes JL, O'Brien PC, Litchy WJ, Low PA, Melton LJ, III. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology 1992;42:1164-1170.
27. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ, III, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic test. Neurology 1991;41:799-807.
28. Dyck PJB, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999;53:2113-2121.
29. Dyrberg T, Benn J, Christiansen JS, Hilsted J, Nerup J. Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia 1981;20:190-194.
30. Ellenberg M. Impotence in diabetes: the neurologic factor. Ann Intern Med 1971;75:213-219.
31. Ellenberg M, Weber H. Retrograde ejaculation in diabetic neuropathy. Ann Intern Med 1966;65:1237-1246.
32. Ewing DJ, Campbell IW, Burt AA, Clarke BF. Vascular reflexes in diabetic autonomic neuropathy. Lancet 1973;2:1354-1356.
33. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. QJ Med 1980;49:95-108.
34. Ewing DJ, Campbell IW, Murray A, Neilson JM, Clarke BF. Immediate heart rate response to standing: simple test of autonomic neuropathy in diabetes. Br Med J 1978;1:145-147.
35. Fagius J. Syndromes of autonomic overactivity: clinical presentation, assessment, and management. In: Low PA, editor. Clinical autonomic disorders: evaluation and management. Boston: Little, Brown; 1993. p 197-208.
36. Fagius J, Westerberg CE, Olsson Y. Acute pandysautonomia and severe sensory deficit with poor recovery. A clinical, neurophysiological and pathological case study. J Neurol Neurosurg Psychiatry 1983;46:725-733.
37. Faich GA, Graebner RW, Sato S. Failure of guanidine therapy in botulism A. N Engl J Med 1971;285:773-776.
38. Feldman EL, Bromberg MB, Blaivas M,Junck L. Acute pandysautonomic neuropathy. Neurology 1991;41:746-748.
39. Fraser DM, Campbell IW, Miller HC. Peripheral and autonomic neuropathy after treatment with perhexiline maleate. Br Med J 1977;2:675-676.
40. Frimodt-Moller C. Diabetic cystopathy. A clinical study of the frequency of bladder. Dan Med Bull 1976;23:267-279.
41. Gertz MA, Rajkumar SV. Primary systemic amyloidosis. Curr Treat Options Oncol 2002;3:261-271.
42. Hancock BW, Naysmith A. Vincristine-induced autonomic neuropathy. Br Med J 1975;3:207.
43. Hart RG, Kanter MC. Acute autonomic neuropathy. Two cases and a clinical review. Arch Intern Med 1990;150:2373-2376.
44. Heafield MT, Gammage MD, Nightingale S, Williams AC. Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet 1996;347:28-29.
45. Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 1999;53:1634-1640.
46. Hilsted J, Low PA. Diabetic autonomic neuropathy. In: Low PA, editor. Clinical autonomic disorders: evaluation and management. Boston: Little, Brown; 1993. p 423-443.
47. Hoeldtke RD, Davis KM. The orthostatic tachycardia syndrome: evaluation of autonomic function and treatment with octreotide and ergot alkaloids. J Clin Endocrinol Metab 1991;73:132-139.
48. Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998;44:47-59.
49. Hongo M, Urushibata K, Kai R, Takahashi W, Koizumi T, Uchikawa S, Imamura H, Kinoshita O, Owa M, Fujii T. Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis. Am Heart J 2002;144:122-129.
50. Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M, Biaggioni I, Ertl A, Black B, Robertson D. The neuropathic postural tachycardia syndrome. N Engl J Med 2000;343:1008-1014.
51. Jacobs JM, Costa-Jussa FR. The pathology of amiodarone neurotoxicity. II. Peripheral neuropathy in man. Brain 1985;108:753-769.
52. Jamal GA, Hansen S, Weir AI, Ballantyne JP. The neurophysiologic investigation of small fiber neuropathies. Muscle Nerve 1987;10:537-545.
53. Kiuru S, Matikainen E, Kupari M, Haltia M, Palo J. Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J Neurol Sci 1994;126:40-48.
54. Kiuru-Enari S, Somer H, Seppalainen AM, Notkola IL, Haltia M. Neuromuscular pathology in hereditary gelsolin amyloidosis. J Neuropathol Exp Neurol 2002;61:565-571.
55. Kwon JM, Elliott JL, Yee WC, Ivanovich J, Scavarda NJ, Moolsintong PJ, Goodfellow PJ. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet 1995;57:853-858.
56. Kyle RA, Dyck PJ. Amyloidosis and neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy, 3rd ed. Philadelphia: WB Saunders; 1993. p 1294-1309.
57. Kyle RA, Greipp PR. Amyloidosis: clinical and laboratory features in 229 cases. Mayo Clin Proc 1983;58:665-683.
58. Lee HR, Lennon VA, Camilleri M, Prather CM. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol 2001;96:373-379.
59. Legha SS. Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol 1986;1:421-427.
60. LeQuesne PM, McLeod JG. Peripheral neuropathy following a single exposure to arsenic. J Neurol Sci 1977;32:437-451.
61. Levy E, Haltia M, Fernandez-Madrid I, Koivunen O, Ghiso J, Prelli F, Frangione B. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 1990;172:1865-1867.
62. Low PA, Caskey PE, Tuck RR, Fealey RD, Dyck PJ. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983;14:573-580.
63. Low PA, Dyck PJ, Lambert EH, Brimijoin WS, Trautmann JC, Malagelada JR, Fealey RD, Barrett DM. Acute panautonomic neuropathy. Ann Neurol 1983;13:412-417.
64. Low PA, McLeod JG. Autonomic neuropathies. In: Low PA, editor. Clinical autonomic disorders: evaluation and management, 2nd ed. Philadelphia: Lippincott-Raven; 1997. p 463-486.
65. Low PA, Opfer-Gehrking TL, McPhee BR, Fealey RD, Benarroch EE, Willner CL, Suarez GA, Proper CJ, Felten JA, Huck CA, Corfits JL. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 1995;70:617-622.
66. Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen WK, Schondorf R, Suarez GA, Rummans TA. Postural tachycardia syndrome (POTS). Neurology 1995;45:S19-S25.
67. Low PA, Suarez GA. Diabetic neuropathies. Baillieres Clin Neurol 1995;4:401-425.
68. Low PA, Walsh JC, Huang CY, McLeod JG. The sympathetic nervous system in diabetic neuropathy. A clinical and pathological study. Brain 1975;98:341-356.
69. Low PA, Zimmerman BR, Dyck PJ. Comparison of distal sympathetic with vagal function in diabetic neuropathy. Muscle Nerve 1986;9:592-596.
70. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 1998;50:652-657.
71. Mahloudji M, Brunt PW, McKusick VA. Clinical neurological aspects of familial dysautonomia. J Neurol Sci 1970;11:383-395.
72. Manolis AS, Tordjman T, Mack KD, Estes NA, III. Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature. Arch Intern Med 1987;147:1805-1809.
73. Martinez-Arizala A, Sobol SM, McCarty GE, Nichols BR, Rakita L. Amiodarone neuropathy. Neurology 1983;33:643-645.
74. Matikainen E, Juntunen J. Autonomic nervous system dysfunction in workers exposed to organic solvents. J Neurol Neurosurg Psychiatry 1985;48:1021-1024.
75. Maury CP, Liljestrom M, Boysen G, Tornroth T, de la Chapelle A, Nurmiaho-Lassila EL. Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type). J Clin Pathol 2000;53:95-99.
76. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia 1980;18:279-283.
77. McCulloch DK, Young RJ, Prescott RJ, Campbell IW, Clarke BF. The natural history of impotence in diabetic men. Diabetologia 1984;26:437-440.
78. Meier C, Kauer B, Muller U, Ludin HP. Neuromyopathy during chronic amiodarone treatment. A case report. J Neurol 1979;220:231-239.
79. Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1969;1:314-324.
80. Mericle RA, Triggs WJ. Treatment of acute pandysautonomia with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1997;62:529-531.
81. Murray A, Ewing DJ, Campbell IW, Neilson JM, Clarke BF. RR interval variations in young male diabetics. Br Heart J 1985;37:882-885.
82. Neville BG, Sladen GE. Acute autonomic neuropathy following primary herpes simplex infection. J Neurol Neurosurg Psychiatry 1984;47:648-650.
83. Nolano M, Crisci C, Santoro L, Barbieri F, Casale R, Kennedy WR, Wendelschafer-Crabb G, Provitera V, Di Lorenzo N, Caruso G. Absent innervation of skin and sweat glands in congenital insensitivity to pain with anhidrosis. Clin Neurophysiol 2000;111:1596-1601.
84. Novak V, Freimer ML, Kissel JT, Sahenk Z, Periquet IM, Nash SM, Collins MP, Mendell JR. Autonomic impairment in painful neuropathy. Neurology 2001;56:861-868.
85. Olofsson BO, Eriksson P, Eriksson A. The sick sinus syndrome in familial amyloidosis with polyneuropathy. Int J Cardiol 1983;4:71-73.
86. Palumbo PJ, Elveback LR, Whisnant JP. Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. Adv Neurol 1978;19:593-601.
87. Pavesi G, Gemignani F, Macaluso GM, Ventura P, Magnani G, Fiocchi A, Medici D, Marbini A, Mancia D. Acute sensory and autonomic neuropathy: possible association with Coxsacki B virus infection. J Neurol Neurosurg Psychiatry 1992;55:613-615.
88. Pellissier JF, Pouget J, Cros D, De Victor B, Serratrice G, Toga M. Peripheral neuropathy induced by amiodarone chlorhydrate. A clinicopathological study. J Neurol Sci 1984;63:251-266.
89. Periquet MI, Novak V, Collins MP, Nagaraja HN, Erdem S, Nash SM, Freimer ML, Sahenk Z, Kissel JT, Mendell JR. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 1999;53:1641-1647.
90. Pickett JB. AAEE case report #16: Botulism. Muscle Nerve 1988;11:1201-1205.
91. Prather CM, Camilleri M. Gastrointestinal dysfunction: approach to management. In: Low PA, editor. Clinical autonomic disorders: evaluation and management, 2nd ed. Philadelphia: Lippincott-Raven; 1997. p 597-612.
92. Prather CM, Camilleri M. Gastrointestinal manifestations of autonomic neuropathy. In: Low PA, editor. Clinical autonomic disorders: evaluation and management. Boston: Little, Brown; 1993. p 551-565.
93. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993;10:820-824.
94. Rosenfeld CS, Broder LE. Cisplatin-induced autonomic neuropathy. Cancer Treat Rep 1984;68:659-660.
95. Saenz de Tejada I, Goldstein I, Azaclzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989;320:1025-1030.
96. Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ. Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med 1990;75:635-646.
97. Sandroni P, Novak V, Opfer-Gehrking TL, Huck CA, Low PA. Mechanisms of blood pressure alterations in response to the Valsalva maneuver in postural tachycardia syndrome. Clin Auton Res 2000;10:1-5.
98. Santoro L, Barbieri F, Nucciotti R, Battaglia F, Crispi F, Ragno M, Greco P, Caruso G. Amiodarone-induced experimental acute neuropathy in rats. Muscle Nerve 1992;15:788-795.
99. Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 1993;43:132-137.
100. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 2000;342:541-549.
101. Shaw JE, Parker R, Hollis S, Gokal R, Boulton AJ. Gustatory sweating in diabetes mellitus. Diabet Med 1996;13:1033-1037.
102. Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP, Liebert CB, Chadwick B, Idelson M, Reznik L, Robbins C, Makalowska I, Brownstein M, Krappmann D, Scheidereit C, Maayan C, Axelrod FB, Gusella JF. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 2001;68:598-605.
103. Smit AAJ, Vermeulen M, Koelman JHTM, Wieling W. An unusual recovery in a patient with acute pandysautonomia after intravenous immunoglobulin therapy. Clin Auton Res 1995;5:323A.
104. Solaro C, Schenone A, Di Sapio A, Pradotto L, Mancardi GL, Primavera A, Mauro A. An Italian family with Ala-47 transt-hyretin mutation associated with cardiomyopathy and polyneuropathy. Neuromuscul Disord 2000;10:52-55.
105. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993;43:288-294.
106. Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995;60:512-521.
107. Stevens MJ, Dayanikli F, Raffel DM, Allman KC, Sandford T, Feldman EL, Wieland DM, Corbett J, Schwaiger M. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol 1998;31:1575-1584.
108. Stewart JD, Low PA, Fealey RD. Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve 1992;15:661-665.
109. Stewart PM, Hensley WJ. An acute attack of variegate porphyria complicated by severe autonomic neuropathy. Aust N Z J Med 1981;11:82-83.
110. Stoll G, Thomas C, Reiners K, Schober R, Hartung HP. Encephalo-myelo-radiculo-ganglionitis presenting as pandysautonomia. Neurology 1991;41:723-726.
111. Suarez GA, Fealey RD, Camilleri M, Low PA. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 1994;44:1675-1682.
112. Taubner RW, Salanova V. Acute dysautonomia and polyneuropathy. Arch Neurol 1984;41:1100-1101.
113. Venkataraman S, Alexander M, Gnanamuthu C. Postinfectious pandysautonomia with complete recovery after intravenous immunoglobulin therapy. Neurology 1998;51:1764-1765.
114. Vernino S, Cheshire WP, Lennon VA. Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci 2001;88:187-192.
115. Vernino S, Lennon VA. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 2000;47:297-305.
116. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000;343:847-855.
117. Vita G, Girlanda P, Puglisi RM, Marabello L, Messina C. Cardiovascular-reflex testing and single-fiber electromyography in botulism. A longitudinal study. Arch Neurol 1987;44:202-206.
118. Warkany J, Hubbard DM. Mercury in urine of children with acrodynia. Lancet 1948;1:829-830.
119. Weinshilboum RM, Axelrod J. Reduced plasma dopamine beta-hydroxylase activity in familial dysautonomia. N Engl J Med 1971;285:938-942.
120. Windebank AJ, Bonkovsky HL. Porphyric neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy, 3rd ed. Philadelphia: WB Saunders; 1993. p 1161-1168.
121. Yahr MD, Frontera AT. Acute autonomic neuropathy. Its occurrence in infectious mononucleosis. Arch Neurol 1975;32:132-133.
122. Young RR, Asbury AK, Adams RD, Corbett JL. Pure pandysautonomia with recovery. Trans Am Neurol Assoc 1969;94:355-357.
123. Young RR, Asbury AK, Corbett JL, Adams RD. Pure pandysautonomia with recovery. Description and discussion of diagnostic criteria. Brain 1975;98:613-636.
124. Zochodne DW. Autonomic involvement in Guillain-Barré syndrome: a review. Muscle Nerve 1994;17:1145-1155.